Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury

Pharmaceutical Biology

Volumn 50, Issue 10, 2012, Pages 1281-1288

  Han, Chang Woo ^a   Kang, Eun Sil ^b   Ham, Sun Ah ^b   Woo, Hong Jung ^c   Lee, Jang Hoon ^c   Seo, Han Geuk ^b  

^a Pusan National University   (South Korea)

^b Konkuk University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Alisma orientale; C Jun NH2 terminal kinase; HepG2; Nonalcoholic fatty liver disease; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALDEHYDE; ALISMA ORIENTALE EXTRACT; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LONG CHAIN FATTY ACID; PALMITIC ACID; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ALISMA ORIENTALE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HERB; HUMAN; HUMAN CELL; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STEATOSIS;

ALISMA; ANTIOXIDANTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CYTOPROTECTION; FATTY LIVER; HEP G2 CELLS; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MEDICINE, EAST ASIAN TRADITIONAL; OXIDATIVE STRESS; PALMITATES; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

ALISMA ORIENTALE; ALISMATACEAE;

EID: 84866060773     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.673629     Document Type: Article

References (42)

1. Adler V, Yin Z, Tew KD, Ronai Z. (1999). Role of redox potential and reactive oxygen species in stress signaling. Oncogene, 18, 6104-6111.
2. Ammendrup A, Maillard A, Nielsen K, Aabenhus Andersen N, Serup P, Dragsbaek Madsen O, Mandrup-Poulsen T, Bonny C. (2000). The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes, 49, 1468-1476.
3. Angulo P. (2002). Nonalcoholic fatty liver disease. N Engl J Med, 346, 1221-1231.
4. Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JM. (1989). The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex. Biochem J, 258, 617-620. (Pubitemid 19075542)
5. Barreyro FJ, Kobayashi S, Bronk SF, Werneburg NW, Malhi H, Gores GJ. (2007). Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem, 282, 27141-27154. (Pubitemid 47501972)
6. Becker EB, Howell J, Kodama Y, Barker PA, Bonni A. (2004). Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci, 24, 8762-8770. (Pubitemid 39362971)
7. Bergamini CM, Gambetti S, Dondi A, Cervellati C. (2004). Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des, 10, 1611-1626. (Pubitemid 38559774)
8. Browning JD, Horton JD. (2004). Molecular mediators of hepatic steatosis and liver injury. J Clin Invest, 114, 147-152. (Pubitemid 39071617)
9. Brunet S, Thibault L, Lepage G, Seidman EG, Dub N, Levy E. (2000). Modulation of endoplasmic reticulum-bound cholesterol regulatory enzymes by iron/ascorbate-mediated lipid peroxidation. Free Radic Biol Med, 28, 46-54. (Pubitemid 30045572)
10. Cazanave SC, Mott JL, Elmi NA, Bronk SF, Werneburg NW, Akazawa Y, Kahraman A, Garrison SP, Zambetti GP, Charlton MR, Gores GJ. (2009). JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem, 284, 26591-26602.
11. Chalasani N, Deeg MA, Crabb DW. (2004). Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 99, 1497-1502. (Pubitemid 39193189)
12. Chen HW, Hsu MJ, Chien CT, Huang HC. (2001). Effect of alisol B acetate, a plant triterpene, on apoptosis in vascular smooth muscle cells and lymphocytes. Eur J Pharmacol, 419, 127-138.
13. Chou CC, Pan SL, Teng CM, Guh JH. (2003). Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells. Eur J Pharm Sci, 19, 403-412. (Pubitemid 36952402)
14. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. (2001). Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev, 53, 135-159. (Pubitemid 32173112)
15. Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Dam JK, Haaland T, Lerg EM, Arntsen B, Birkeland K, Bjö K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B. (2010). Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 95, 3039-3047.
16. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. (2003). Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology, 125, 437-443. (Pubitemid 36929425)
17. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J. (2004). Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol, 18, 2024-2034. (Pubitemid 39006506)
18. Hensley K, Kotake Y, Sang H, Pye QN, Wallis GL, Kolker LM, Tabatabaie T, Stewart CA, Konishi Y, Nakae D, Floyd RA. (2000). Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria. Carcinogenesis, 21, 983-989. (Pubitemid 30265144)
19. Hii CS, Huang ZH, Bilney A, Costabile M, Murray AW, Rathjen DA, Der CJ, Ferrante A. (1998). Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promyelocytic leukemic cells, and human neutrophils. Evidence for cell typespecific activation of mitogen-activated protein kinases. J Biol Chem, 273, 19277-19282. (Pubitemid 28366328)
20. Hong X, Tang H, Wu L, Li L. (2006). Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J Pharm Pharmacol, 58, 1391-1398. (Pubitemid 44580570)
21. Jaeschke A, Davis RJ. (2007). Metabolic stress signaling mediated by mixed-lineage kinases. Mol Cell, 27, 498-508. (Pubitemid 47126942)
22. Kang ES, Woo IS, Kim HJ, Eun SY, Paek KS, Kim HJ, Chang KC, Lee JH, Lee HT, Kim JH, Nishinaka T, Yabe-Nishimura C, Seo HG. (2007). Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic Biol Med, 43, 535-545. (Pubitemid 47058231)
23. Kang ES, Iwata K, Ikami K, Ham SA, Kim HJ, Chang KC, Lee JH, Kim JH, Park SB, Kim JH, Yabe-Nishimura C, Seo HG. (2011). Aldose reductase in keratinocytes attenuates cellular apoptosis and senescence induced by UV radiation. Free Radic Biol Med, 50, 680-688.
24. Kubo M, Matsuda H, Tomohiro N, Yoshikawa M. (1997). Studies on Alismatis rhizoma. I. Anti-allergic effects of methanol extract and six terpene components from Alismatis rhizoma (dried rhizome of Alisma orientale). Biol Pharm Bull, 20, 511-516. (Pubitemid 27250636)
25. Lee SM, Kim JH, Zhang Y, An RB, Min BS, Joung H, Lee HK. (2003). Anti-complementary activity of protostane-type triterpenes from Alismatis rhizoma. Arch Pharm Res, 26, 463-465. (Pubitemid 43073814)
26. Malhi H, Bronk SF, Werneburg NW, Gores GJ. (2006). Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem, 281, 12093-12101. (Pubitemid 43855473)
27. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. (1999). Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med, 107, 450-455. (Pubitemid 29528333)
28. Matsuda H, Tomohiro N, Yoshikawa M, Kubo M. (1998). Studies on Alismatis Rhizoma. II. Anti-complementary activities of methanol extract and terpene components from Alismatis Rhizoma (dried rhizome of Alisma orientale). Biol Pharm Bull, 21, 1317-1321. (Pubitemid 29021793)
29. Matsuda H, Kageura T, Toguchida I, Murakami T, Kishi A, Yoshikawa M. (1999). Effects of sesquiterpenes and triterpenes from the rhizome of Alisma orientale on nitric oxide production in lipopolysaccharide-activated macrophages: absolute stereostructures of alismaketones-B 23-acetate and-C 23-acetate. Bioorg Med Chem Lett, 9, 3081-3086. (Pubitemid 29515386)
30. Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, Nabemoto S, Kurita S, Ota T, Ando H, Miyamoto K, Kaneko S. (2009). Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem, 284, 14809-14818.
31. Narasimhan S, Gokulakrishnan K, Sampathkumar R, Farooq S, Ravikumar R, Mohan V, Balasubramanyam M. (2010). Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem, 43, 815-821.
32. Nehra V, Angulo P, Buchman AL, Lindor KD. (2001). Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci, 46, 2347-2352. (Pubitemid 33042332)
33. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, Sanyal AJ. (2008). Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology, 134, 568-576. (Pubitemid 351173040)
34. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, Amorino G, Valerie K, Sealy L, Engelhardt JF, Grant S, Hylemon PB, Dent P. (2003). Bile acid regulation of C/EBPβ, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol, 23, 3052-3066. (Pubitemid 36459221)
35. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. (2001). Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120, 1183-1192. (Pubitemid 32246672)
36. Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ. (2006). JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology, 43, 163-172. (Pubitemid 43733603)
37. Shen HM, Liu ZG. (2006). JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med, 40, 928-939.
38. Singh R, Wang Y, Xiang Y, Tanaka KE, Gaarde WA, Czaja MJ. (2009). Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology, 49, 87-96.
39. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science, 287, 664-666. (Pubitemid 30070916)
40. Wei Y, Wang D, Topczewski F, Pagliassotti MJ. (2006). Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab, 291, E275-E281. (Pubitemid 44035286)
41. Xiu RJ. (1988). Microcirculation and traditional Chinese medicine. JAMA, 260, 1755-1757.
42. Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, Dagalp K. (2005). Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am J Gastroenterol, 100, 850-855. (Pubitemid 40592378)